Pfizer

Creative agency working with Tesco and Pfizer moves to employee ownership - Initium advises Insider Media08:17
Will Pfizer (PFE) beat estimates again in its next earnings report? Zacks18:19
Pfizer earnings preview: What to expect Barchart17:22
Pfizer (PFE) ascends while market falls: Some facts to note Zacks23:49
Pfizer’s Sally Susman to step down at year’s end amid broader restructuring PRWeek16:22
Pfizer’s reputation chief leaving as company shuffles executives Bloomberg Law16:28

Latest News

In the last 4 hours
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know Zacks15:00
Earlier today
Creative agency working with Tesco and Pfizer moves to employee ownership - Initium advises Insider Media08:17
In the last 7 days
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report? Zacks18:19 11-Jul-25
Pfizer and Astellas’ Xtandi improves OS as combination therapy Clinical Trials Arena14:28 11-Jul-25
Pfizer, Sanofi Find Relief As Delaware Top Court Rejects Zantac Expert Testimony Benzinga14:05 11-Jul-25
Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study Benzinga20:07 10-Jul-25
Pfizer, Astellas boost case for Xtandi in early-stage prostate cancer with combo survival win FiercePharma17:02 10-Jul-25
AbbVie pays $700M upfront for trispecific rival to J&J, Pfizer in blood cancer FiercePharma16:21 10-Jul-25
EU President fends off no-confidence vote over Pfizer texts pharmaphorum14:18 10-Jul-25
EU Commission chief von der Leyen survives no-confidence vote in European Parliament Yeni Şafak13:03 10-Jul-25
No Confidence? Ursula von der Leyen Crushes Attempt to Be Ousted Over Pfizer Secrets Novinite12:53 10-Jul-25
Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win Reuters12:40 10-Jul-25
EU’s von der Leyen wins confidence vote over Pfizer texts Luxembourg Times12:00 10-Jul-25
Xtandi® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic… Business Wire (Press Release)11:50 10-Jul-25
Ex-Pfizer Immigration Lead Joins Jackson Lewis In NY Law36020:09 9-Jul-25
Pfizer Earnings Preview: What to Expect Barchart17:22 9-Jul-25
JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now? Zacks15:24 9-Jul-25
Pfizer, Mphasis to Johnson Controls-Hitachi: 5 Key stocks to trade Ex-dividend today Mint04:55 9-Jul-25
Pfizer (PFE) Ascends While Market Falls: Some Facts to Note Zacks23:49 8-Jul-25
Edited video of Pfizer CEO circulates again online Full Fact17:35 8-Jul-25
Pfizer’s Reputation Chief Leaving as Company Shuffles Executives Bloomberg Law16:28 8-Jul-25
Pfizer’s Sally Susman to step down at year’s end amid broader restructuring PRWeek16:22 8-Jul-25
Sally Susman To Depart Pfizer After Nearly Two Decades PRovoke16:16 8-Jul-25
Protein degraders: chasing undruggable targets BioPharma Dive13:42 8-Jul-25
Kinase Inhibitors in Autoimmune Diseases Market to Surge in 2035 – Bis Research Industry Today09:23 8-Jul-25
Dividend stocks: Pfizer, 6 others to go ex-date on July 9; do you own any? The Business Standard03:43 8-Jul-25
Mphasis, 6 other stocks to trade ex-dividend tomorrow. Last opportunity to buy for benefit The Economic Times03:18 8-Jul-25
In the last month
Dividend stocks: Sun Pharma, Idfc First Bank, Jsw Steel, others to trade ex-dividend next week; … Mint18:14 5-Jul-25
Should You Buy Pfizer Limited (NSE:PFIZER) For Its Upcoming Dividend? Simply Wall St05:55 5-Jul-25
Pfizer: Options Activity Speaks Bullish Seeking Alpha02:39 5-Jul-25
Ghana: Ministry of Health Strengthens Partnership With Pfizer to Advance Equitable Healthcare AllAfrica17:45 4-Jul-25
2 Stocks to Buy With Less Than $50 The Motley Fool14:55 4-Jul-25
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (July 2025) 24/7 Wall St.14:04 4-Jul-25
Pfizer and Bristol-Myers Squibb’s Promising Study on Multiple Myeloma Treatment TipRanks17:27 3-Jul-25
Pfizer’s Observational Study on Refractory Multiple Myeloma: A Glimpse into Italian Clinical… TipRanks17:27 3-Jul-25
Pfizer’s ARV-471: A Promising New Hope for Advanced Breast Cancer TipRanks17:27 3-Jul-25
MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations Zacks15:18 3-Jul-25
Pfizer Trades Above 50-Day Average for a Month: Time to Buy? Zacks14:58 3-Jul-25
Bondi made changes to DOJ policy. Her former client Pfizer might have benefited Miami Herald10:36 3-Jul-25
Pfizer (PFE) Outperforms Broader Market: What You Need to Know Zacks23:54 2-Jul-25
Industry could feel fallout of Pfizer vaccine scrutiny BioWorld22:15 2-Jul-25
Pfizer: Competitive Advantages Still Exist, but Signs of Erosion Lead Us to Lower Our Valuation MorningStar.com20:02 2-Jul-25
Lawmakers Investigate Whether Pfizer Delayed Covid-19 Vaccine Results For Political Reasons Benzinga18:33 2-Jul-25
Huge Unusual Volume in Pfizer Put Options Signals Investors Bullish Outlook Barchart18:33 2-Jul-25
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple… FiercePharma16:38 2-Jul-25
Republicans subpoena former Pfizer exec over timing of Covid vaccine clinical tests Fox News15:37 2-Jul-25
Alnylam Beats Acuitas Claim on Patents in Pfizer Covid-Shot Suit Bloomberg Law15:17 2-Jul-25
Pfizer terminates study of CD47 in blood cancer due to low recruitment Clinical Trials Arena11:33 2-Jul-25
Pfizer's Strong Late-Stage Pipeline Can Drive Long-Term Growth Zacks15:39 1-Jul-25
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock Zacks15:08 1-Jul-25
STAT Plus: Pharmalittle: We’re reading about Novo’s Wegovy launch gaffes, a former Pfizer… STAT14:20 1-Jul-25
House Subpoenas Ex-Pfizer Scientist in Election Meddling Probe Bloomberg Law22:08 30-Jun-25
TCTMD’s Top 10 Most Popular Stories for June 2025 TCTMD18:31 30-Jun-25
Texas v. Pfizer, Inc. U.S. Chamber of Commerce (Press Release)15:27 30-Jun-25
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and… PR Newswire (Press Release)02:24 30-Jun-25
Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," June 29, 2025 CBS News17:19 29-Jun-25
Pfizer’s Bold Clinical Trials Could Boost Stock Performance TipRanks16:10 28-Jun-25
3 No-Brainer Stocks to Buy for Under $100 Right Now The Motley Fool12:27 28-Jun-25
Pfizer’s New Clinical Study on PF-07985631: A Potential Game-Changer for Kidney Disease TipRanks17:38 27-Jun-25
Pfizer’s Promising Study on Rimegepant for Adolescent Migraine Prevention TipRanks17:28 27-Jun-25
Pfizer’s Latest Study on Elranatamab: A Potential Game-Changer in Multiple Myeloma Treatment? TipRanks17:28 27-Jun-25
Pfizer’s New Phase 1 Study: A Closer Look at PF-07899895 TipRanks17:18 27-Jun-25
Pfizer’s Prevnar 20 Study: A Potential Game-Changer for Elderly Pneumonia Prevention TipRanks17:08 27-Jun-25
Pfizer’s ATGAM Study: A Closer Look at Safety in Aplastic Anemia Treatment TipRanks17:08 27-Jun-25
US House committee subpoenas former Pfizer executive over alleged COVID vaccine delay Reuters14:55 27-Jun-25
Pfizer shares positive phase 3 results for haemophilia A and B therapy Hympavzi PMLiVE12:37 27-Jun-25
Pfizer's Hympavzi meets primary and secondary endpoints in Phase III BASIS trial Manufacturing Chemist12:17 27-Jun-25
Pfizer reports positive results from Phase III BAISIS trial for haemophilia Clinical Trials Arena11:31 27-Jun-25
Pfizer’s Hympavzi Poised For Broader Hemophilia Label Scrip Pharma Intelligence22:58 26-Jun-25
FDA Updates CV Warnings Around COVID-19 mRNA Vaccines TCTMD21:25 26-Jun-25
Pfizer Seeks Label Expansion For Hemophilia Drug After Promising Data Benzinga19:06 26-Jun-25
All You Need to Know About Pfizer (PFE) Rating Upgrade to Buy Zacks18:05 26-Jun-25
Pfizer’s Promising Pediatric Migraine Study: A Potential Game-Changer? TipRanks17:43 26-Jun-25
Pfizer’s Promising Phase 3 Trial: A New Hope for Multiple Myeloma Treatment TipRanks17:43 26-Jun-25
Pfizer’s Promising Clinical Trial for Relapsed Refractory Multiple Myeloma TipRanks17:43 26-Jun-25
Pfizer’s Promising Phase 3 Study on Ibuzatrelvir for COVID-19 TipRanks17:33 26-Jun-25
Pfizer’s Elranatamab Study: A Boost for Multiple Myeloma Patients and Investor Confidence TipRanks17:33 26-Jun-25
Pfizer’s Rimegepant Study: A Potential Game-Changer in Migraine Prevention TipRanks17:23 26-Jun-25
Pfizer’s Ongoing Study on COVID-19 and Influenza: What Investors Need to Know TipRanks17:23 26-Jun-25
Pfizer’s Rimegepant Study: Assessing Safety in Pregnancy TipRanks17:13 26-Jun-25
Pfizer’s New Phase 1 Study on PF-07832837: A Potential Game-Changer for Atopic Dermatitis TipRanks17:13 26-Jun-25
Pfizer’s New Study on Atrial Fibrillation: What Investors Need to Know TipRanks17:13 26-Jun-25
Pfizer’s Promising Phase 2 Study on Atopic Dermatitis Treatment TipRanks17:13 26-Jun-25
Pfizer’s Study on Aromatase Inhibitors in Taiwan: Key Insights for Investors TipRanks17:13 26-Jun-25
Pfizer’s Obesity Treatment Study: A Potential Game-Changer for the Market TipRanks17:03 26-Jun-25
Pfizer's hemophilia drug Hympavzi notches phase 3 win as pharma eyes label expansion FiercePharma13:08 26-Jun-25
Pfizer Announces Positive Topline Phase 3 Results for Hympavzi™ in Hemophilia A or B with… Business Wire (Press Release)11:49 26-Jun-25
The startups that grew out of the Pfizer redundancies Chemistry World Magazine09:39 26-Jun-25
Pfizer Could Be The Turnaround Story In The Pharmaceutical Space Seeking Alpha09:31 26-Jun-25
Don't Sleep On Pfizer: The Turnaround Is Just Getting Started Seeking Alpha09:31 26-Jun-25
Heads up: Far-right lawmakers look to table no confidence vote against EU's von der Leyen ForexLive.com06:30 26-Jun-25
Pfizer Declares Third-Quarter 2025 Dividend Business Wire (Press Release)22:37 25-Jun-25
Top stock price forecast: Plug Power, Uber, and Pfizer Invezz17:32 25-Jun-25
Pfizer’s New Phase 1 Study: Exploring PF-07999415’s Potential TipRanks17:17 25-Jun-25
Pfizer’s Inclacumab Study: A Long-term Safety Evaluation for Sickle Cell Disease TipRanks17:17 25-Jun-25
Pfizer’s New Study on PF-07985631: A Potential Breakthrough for IgA Nephropathy TipRanks17:17 25-Jun-25
Pfizer and BioNTech’s New Shingles Vaccine Study: What Investors Need to Know TipRanks17:17 25-Jun-25
Pfizer’s New Study on Rimegepant: A Potential Game-Changer for Adolescent Migraine Prevention TipRanks17:07 25-Jun-25
Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts Business Wire (Press Release)15:03 25-Jun-25
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing Zacks23:50 24-Jun-25
I was a healthy father-of-four until I had the Pfizer Covid vaccine - what happened next… MailOnline21:01 24-Jun-25
Pfizer’s Phase 3 Study on Ibuzatrelvir: A Potential Game Changer in COVID-19 Treatment TipRanks17:13 24-Jun-25
Pfizer’s Rimegepant Study: A Potential Game-Changer in Pediatric Migraine Prevention TipRanks17:13 24-Jun-25
Pfizer’s Phase 3 Study on Elranatamab: A Potential Game-Changer for Multiple Myeloma Treatment TipRanks17:13 24-Jun-25
Pfizer’s Promising Phase 3 Study on Elranatamab in Multiple Myeloma TipRanks17:13 24-Jun-25
Pfizer’s Promising Phase 1B Trial for Multiple Myeloma: Key Insights for Investors TipRanks17:13 24-Jun-25
Pfizer’s Elranatamab Study: A Lifeline for Multiple Myeloma Patients TipRanks17:03 24-Jun-25
Pfizer’s Promising Phase 3 Study on Rimegepant for Menstrual Migraine Prevention TipRanks17:03 24-Jun-25
Pfizer’s New Study on Elranatamab: A Potential Game-Changer in Multiple Myeloma Treatment TipRanks17:03 24-Jun-25
Pfizer to Face Several Headwinds: Can It Successfully Navigate Them? Zacks16:32 24-Jun-25
FDA, CDC advisers say lost pregnancies higher than expected following early mRNA vaccination Just The News03:53 24-Jun-25
ADA: Lilly makes its case for oral GLP-1 orforglipron pharmaphorum11:40 23-Jun-25
Pfizer: An Offensive Play For A Bear Market Seeking Alpha18:36 22-Jun-25
Lantheus Holdings (NasdaqGM:LNTH) Joins FIBRE Consortium To Transform Fibrotic Disease Treatment Simply Wall St00:00 21-Jun-25
Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now? Zacks16:12 20-Jun-25

      
            
      
    view more headlines
   
      
      
      
14 Jul 15:00
   

Pfizer News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Pfizer news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Pfizer

Latest News

Pfizer News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories